These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 18028834)
1. MS therapy research applying genome-wide RNA profiling of peripheral blood. Goertsches R; Zettl UK Int MS J; 2007 Sep; 14(3):98-107. PubMed ID: 18028834 [TBL] [Abstract][Full Text] [Related]
2. [Therapy monitoring in patients with multiple sclerosis based on transcriptomic analysis]. Zettl UK; Goertsches RH Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S64-8. PubMed ID: 19685398 [TBL] [Abstract][Full Text] [Related]
5. RNA profiling of MS brain tissues. Kinter J; Zeis T; Schaeren-Wiemers N Int MS J; 2008 Jun; 15(2):51-8. PubMed ID: 18782500 [TBL] [Abstract][Full Text] [Related]
6. Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis. Mycko MP; Papoian R; Boschert U; Raine CS; Selmaj KW Clin Neurol Neurosurg; 2004 Jun; 106(3):223-9. PubMed ID: 15177772 [TBL] [Abstract][Full Text] [Related]
7. Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity. Achiron A; Gurevich M; Friedman N; Kaminski N; Mandel M Ann Neurol; 2004 Mar; 55(3):410-7. PubMed ID: 14991819 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment. Lindberg RL; Kappos L Expert Rev Mol Diagn; 2006 Nov; 6(6):843-55. PubMed ID: 17140371 [TBL] [Abstract][Full Text] [Related]
9. Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy. Goertsches RH; Zettl UK; Hecker M Pharmacogenomics; 2011 Mar; 12(3):423-32. PubMed ID: 21449680 [TBL] [Abstract][Full Text] [Related]
10. RNA stabilization of peripheral blood and profiling by bead chip analysis. Debey-Pascher S; Eggle D; Schultze JL Methods Mol Biol; 2009; 496():175-210. PubMed ID: 18839112 [TBL] [Abstract][Full Text] [Related]
11. Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis. Achiron A; Gurevich M Autoimmun Rev; 2006 Oct; 5(8):517-22. PubMed ID: 17027885 [TBL] [Abstract][Full Text] [Related]
12. The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Gandhi KS; McKay FC; Cox M; Riveros C; Armstrong N; Heard RN; Vucic S; Williams DW; Stankovich J; Brown M; Danoy P; Stewart GJ; Broadley S; Moscato P; Lechner-Scott J; Scott RJ; Booth DR; Hum Mol Genet; 2010 Jun; 19(11):2134-43. PubMed ID: 20190274 [TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery? Brynedal B; Khademi M; Wallström E; Hillert J; Olsson T; Duvefelt K Neurobiol Dis; 2010 Mar; 37(3):613-21. PubMed ID: 19944761 [TBL] [Abstract][Full Text] [Related]
14. A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis of peripheral blood applicable to large-scale clinical trials. Debey S; Zander T; Brors B; Popov A; Eils R; Schultze JL Genomics; 2006 May; 87(5):653-64. PubMed ID: 16387473 [TBL] [Abstract][Full Text] [Related]
16. Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation. Sellebjerg F; Krakauer M; Hesse D; Ryder LP; Alsing I; Jensen PE; Koch-Henriksen N; Svejgaard A; Soelberg Sørensen P Eur J Neurol; 2009 Dec; 16(12):1291-8. PubMed ID: 19558503 [TBL] [Abstract][Full Text] [Related]